Can a Blood Test Detect Colorectal Cancer?
A new study shows blood-based screening test is successful in 83% of people with the disease
A new study shows blood-based screening test is successful in 83% of people with the disease
Fuzuloparib with or without apatinib provided superior PFS benefit vs chemotherapy in HER2– metastatic breast cancer harboring germline BRCA1/2 mutations.
PHILADELPHIA (May 8, 2024) — On April 26, 2024, Fox Chase Cancer Center welcomed staff and faculty from Temple Health to the 10th Annual Cultural…
The American Cancer Society plans to follow 100,000 healthy black women for 30 years in the largest-of-its kind study into the demographic’s long- term health…
A new study suggests that starting a patient on preferred targeted therapy within 1 year of metastatic non-small cell lung cancer diagnosis can still improve…
This site uses cookies. By continuing to use our website, you are agreeing to our privacy
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Mohamad Mohty, MD, PhD, highlights key takeaways from the 50th Annual EMBT Meeting, focusing on ongoing efforts within the GVHD treatment arena.
Brain and Other Nervous System Cancer statistics
The panel discusses the lenvatinib plus everolimus regimen for patients with advanced renal cell carcinoma, highlighting clinical trial data on its efficacy and safety profile.
The NCI SBIR Innovation Lab podcast reaches and engages with entrepreneurs of all levels to share insights on commercialization and success stories from biotech industry…